⃛ as US DNA advisory body redefines itself
Meredith Wadman
Nature, 1999, vol. 400, issue 6739, 4-4
Abstract:
washington The Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health, the body which debates new gene-therapy protocols, is proposing to expand its mandate to take into account of new technologies based on RNA or synthetic DNA.
Date: 1999
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/21726 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:400:y:1999:i:6739:d:10.1038_21726
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/21726
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().